Market open
LifeMD/$LFMD
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About LifeMD
LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.
Ticker
$LFMD
Sector
Trading on
Industry
Health Care Technology
Headquarters
Employees
209
Website
LifeMD Metrics
BasicAdvanced
$226M
Market cap
-
P/E ratio
-$0.65
EPS
1.23
Beta
-
Dividend rate
Price and volume
Market cap
$226M
Beta
1.23
52-week high
$12.88
52-week low
$3.99
Average daily volume
693K
Financial strength
Current ratio
0.825
Quick ratio
0.74
Long term debt to equity
-326.826
Total debt to equity
-422.226
Interest coverage (TTM)
-8.83%
Management effectiveness
Return on assets (TTM)
-21.34%
Return on equity (TTM)
260.40%
Valuation
Price to revenue (TTM)
1.077
Price to book
-28.27
Price to tangible book (TTM)
-9.31
Price to free cash flow (TTM)
27.647
Growth
Revenue change (TTM)
42.16%
Earnings per share change (TTM)
-33.71%
3-year revenue growth (CAGR)
35.07%
3-year earnings per share growth (CAGR)
-40.65%
What the Analysts think about LifeMD
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for LifeMD stock.
LifeMD Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
LifeMD Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
LifeMD News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for LifeMD stock?
LifeMD (LFMD) has a market cap of $226M as of December 30, 2024.
What is the P/E ratio for LifeMD stock?
The price to earnings (P/E) ratio for LifeMD (LFMD) stock is 0 as of December 30, 2024.
Does LifeMD stock pay dividends?
No, LifeMD (LFMD) stock does not pay dividends to its shareholders as of December 30, 2024.
When is the next LifeMD dividend payment date?
LifeMD (LFMD) stock does not pay dividends to its shareholders.
What is the beta indicator for LifeMD?
LifeMD (LFMD) has a beta rating of 1.23. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.